ArticleFrontiers in cardiovascular medicine2022

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk.

Ju Hee Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.